With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Identification of Mechanisms of Resistance to Trametinib Monotherapy in PAX-fusion Negative Rhabdomyosarcoma||National Cancer Institute / Marielle Yohe, MD/PhD||Young Investigator Grants||2016||Maryland|
|Modeling Pediatric Spinal Gliomas Using Murine Spinal Neural Stem Cells||The Johns Hopkins University School of Medicine / Charles Eberhart, MD/PhD & Eric Raabe MD/PhD||Innovation Grants||2016||Maryland|
|Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML||Boston Children’s Hospital / Alan Cantor, MD, PhD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||Massachusetts|
|The Role of ARID1A in Neuroblastoma Pathogenesis||Dana-Farber Cancer Institute / Hui Shi, PhD||Young Investigator Grants||2016||Massachusetts|
|Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma||Dana-Farber Cancer Institute / David Debruyne, PhD||Young Investigator Grants||2016||Massachusetts|
|GeneEditing in T cell Leukemia to Promote Immunomodulatory Forms of Cell Death||Boston Children’s Hospital / Dr. Ben Croker, PhD||Innovation Grants||2016||Massachusetts|
|Modeling RUNX1-Associated Clonal Hematopoietic Disorders in Zebrafish||Boston Children’s Hospital / Leonard Zon, MD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||Massachusetts|
|Resistance and Develop Improved Treatments for Relapsed/refractory Pediatric ALL||Dana-Farber Cancer Institute / Elizabeth Townsend, PhD||Young Investigator Grants||2016||Massachusetts|
|Redefining the Cellular Architecture of Diffuse Intrinsic Pontine Glioma through Large-Scale Single-cell RNA-seq Analyses||Massachusetts General Hospital / Mario Suva, MD/PhD||Innovation Grants||2016||Massachusetts|
|A Role for Non-canonical Wnt/PCP Signaling in Growth and Self-Renewal of Embryonal Rhabdomyosarcoma||Massachusetts General Hospital / Madeline Hayes, PhD||Young Investigator Grants||2016||Massachusetts|